Novo Nordisk  

Ischaemic Heart Disease
   

Ischaemic heart disease develops in over three-quarters of people with Type 2 diabetes, and kills half of them.
It is often silent, often accompanied by cardiac failure, and is less amenable to surgical intervention than usual

Assessment and diagnosis
Investigate if :
classical angina or suspicious symptoms
unexplained breathlessness
cardiac failure, cardiomegaly, or cardiac rhythm disorder
arterial thrombotic event
The threshold for investigation is lower if albumin excretion rate is abnormal

Investigate by :
standard 12-lead ECG and chest X-ray
cardiac ultrasound scan
exercise stress ECG
angiography / stress echo if indicated
Management

Intensify :
  management of arterial risk factors ( see also : Managing Arterial Risk Factors )
  education on life-style management including smoking ( see also : Life-style issues, Smoking target, Providing Nutritional Advice and Physical Exercise )

Review
:
  choice of blood pressure lowering drugs ( indication for ß-adrenergic blockers )
use of aspirin / other anti-thrombotic therapy ( all patients )
use of cardiac failure drugs ( indication for ACE-inhibitors )

Advise
:
  early coronary bypass therapy / angioplasty / stenting if indicated

Use
:
  intravenous insulin to control blood glucose levels after admission for myocardial infarction

Consider
:
  hormone replacement therapy in post-menopausal women ( if agreed )
Kidney Damage

 

IDF Guidelines to Type 2 diabetes
Click here for 'Topic Finder'

Click here for 'Diagnose and classify hyperglycaemic states'
Click here for 'Ensure effective delivery of care'
Click here for 'Promote effective self-care through education'
Click here for 'Control blood glucose, blood lipids, blood pressure'
Detect and manage diabetes complications
Ischaemic Heart Disease
Kidney Damage
Eye Damage
Foot Problems
Nerve Damage
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page